NCT00602862: Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250 |
|
|
| Completed | N/A | 26 | Europe | Sorafenib, Bevacizumab, Avastin, Nexavar, cG250, Rencarex, 111Indium-bevacizumab, avastin, indium, 111Indium-cG250, rencarex | Radboud University Medical Center, Dutch Cancer Society | Clear Cell Renal Cell Carcinoma | 04/12 | 06/12 | | |
